277 related articles for article (PubMed ID: 20702811)
1. Resolvin E1 regulates adenosine diphosphate activation of human platelets.
Fredman G; Van Dyke TE; Serhan CN
Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2005-13. PubMed ID: 20702811
[TBL] [Abstract][Full Text] [Related]
2. Rapid resensitization of purinergic receptor function in human platelets.
Mundell SJ; Barton JF; Mayo-Martin MB; Hardy AR; Poole AW
J Thromb Haemost; 2008 Aug; 6(8):1393-404. PubMed ID: 18513210
[TBL] [Abstract][Full Text] [Related]
3. Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets.
Dona M; Fredman G; Schwab JM; Chiang N; Arita M; Goodarzi A; Cheng G; von Andrian UH; Serhan CN
Blood; 2008 Aug; 112(3):848-55. PubMed ID: 18480426
[TBL] [Abstract][Full Text] [Related]
4. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation.
Arita M; Ohira T; Sun YP; Elangovan S; Chiang N; Serhan CN
J Immunol; 2007 Mar; 178(6):3912-7. PubMed ID: 17339491
[TBL] [Abstract][Full Text] [Related]
5. Resolvin E1 receptor activation signals phosphorylation and phagocytosis.
Ohira T; Arita M; Omori K; Recchiuti A; Van Dyke TE; Serhan CN
J Biol Chem; 2010 Jan; 285(5):3451-61. PubMed ID: 19906641
[TBL] [Abstract][Full Text] [Related]
6. The P2 receptors and congenital platelet function defects.
Cattaneo M
Semin Thromb Hemost; 2005 Apr; 31(2):168-73. PubMed ID: 15852220
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270.
Ding Z; Kim S; Dorsam RT; Jin J; Kunapuli SP
Blood; 2003 May; 101(10):3908-14. PubMed ID: 12560222
[TBL] [Abstract][Full Text] [Related]
8. Both the ADP receptors P2Y1 and P2Y12, play a role in controlling shape change in human platelets.
Jagroop IA; Burnstock G; Mikhailidis DP
Platelets; 2003 Feb; 14(1):15-20. PubMed ID: 12623443
[TBL] [Abstract][Full Text] [Related]
9. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
Storey RF; Sanderson HM; White AE; May JA; Cameron KE; Heptinstall S
Br J Haematol; 2000 Sep; 110(4):925-34. PubMed ID: 11054084
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.
Jin J; Daniel JL; Kunapuli SP
J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040
[TBL] [Abstract][Full Text] [Related]
11. Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis.
Ishida T; Yoshida M; Arita M; Nishitani Y; Nishiumi S; Masuda A; Mizuno S; Takagawa T; Morita Y; Kutsumi H; Inokuchi H; Serhan CN; Blumberg RS; Azuma T
Inflamm Bowel Dis; 2010 Jan; 16(1):87-95. PubMed ID: 19572372
[TBL] [Abstract][Full Text] [Related]
12. Ticagrelor binds to human P2Y(12) independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation.
VAN Giezen JJ; Nilsson L; Berntsson P; Wissing BM; Giordanetto F; Tomlinson W; Greasley PJ
J Thromb Haemost; 2009 Sep; 7(9):1556-65. PubMed ID: 19552634
[TBL] [Abstract][Full Text] [Related]
13. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
Puri RN; Colman RF; Colman RW
Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
[TBL] [Abstract][Full Text] [Related]
14. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1.
Arita M; Bianchini F; Aliberti J; Sher A; Chiang N; Hong S; Yang R; Petasis NA; Serhan CN
J Exp Med; 2005 Mar; 201(5):713-22. PubMed ID: 15753205
[TBL] [Abstract][Full Text] [Related]
15. P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms.
Hardy AR; Conley PB; Luo J; Benovic JL; Poole AW; Mundell SJ
Blood; 2005 May; 105(9):3552-60. PubMed ID: 15665114
[TBL] [Abstract][Full Text] [Related]
16. Stromal cell-derived factor-1 and macrophage-derived chemokine: 2 chemokines that activate platelets.
Kowalska MA; Ratajczak MZ; Majka M; Jin J; Kunapuli S; Brass L; Poncz M
Blood; 2000 Jul; 96(1):50-7. PubMed ID: 10891429
[TBL] [Abstract][Full Text] [Related]
17. Adenine triphosphate nucleotides are antagonists at the P2Y receptor.
Kauffenstein G; Hechler B; Cazenave JP; Gachet C
J Thromb Haemost; 2004 Nov; 2(11):1980-8. PubMed ID: 15550030
[TBL] [Abstract][Full Text] [Related]
18. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of P2Y(12) receptor responsiveness to cysteinyl leukotrienes.
Foster HR; Fuerst E; Lee TH; Cousins DJ; Woszczek G
PLoS One; 2013; 8(3):e58305. PubMed ID: 23472176
[TBL] [Abstract][Full Text] [Related]
20. Functional significance of adenosine 5'-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate.
Goto S; Tamura N; Eto K; Ikeda Y; Handa S
Circulation; 2002 May; 105(21):2531-6. PubMed ID: 12034661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
